Literature DB >> 11021508

The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.

P Warrick1, C Dromey, J Irish, L Durkin.   

Abstract

The purpose of this study was to evaluate the effects of bilateral botulinum toxin injection into the thyroarytenoid (TA) muscles of a patient with essential voice tremor. Acoustic and aerodynamic data were collected weekly over a 16-week period. Flexible nasolaryngoscopy was performed prior to injection and 2, 6, 10, and 16 weeks postinjection. Perceptual analyses of the acoustic and nasolaryngoscopic data were performed. A reduction in frequency tremor and, to a lesser extent, amplitude tremor was observed during the 1-10 week period. Estimated laryngeal resistance decreased after injection and was accompanied in perceptual measures by a reduction in vocal effort, laryngeal tremor, and supraglottic hyperfunction. Essential voice tremor can be successfully attenuated with bilateral percutaneous injection of botulinum toxin A into the vocalis muscle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021508     DOI: 10.1016/s0892-1997(00)80086-7

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  12 in total

1.  The effects of physiological adjustments on the perceptual and acoustical characteristics of simulated laryngeal vocal tremor.

Authors:  Rosemary A Lester; Brad H Story
Journal:  J Acoust Soc Am       Date:  2015-08       Impact factor: 1.840

2.  Analysis of the prevalence and onset of dysphonia and dysphagia symptoms in movement disorders at an academic medical center.

Authors:  Mary E Finger; Lyndsay L Madden; Ihtsham U Haq; Christopher J McLouth; Mustafa S Siddiqui
Journal:  J Clin Neurosci       Date:  2019-04-01       Impact factor: 1.961

3.  Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Vahram Gamsarian; Jane Lee; Vishnutheert Kulkarni; C Gaelyn Garrett; David O Francis
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

4.  Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Zaki A Ahmed; Simone C Gruber; Jordan S Akins; C Gaelyn Garrett; David O Francis
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

5.  Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor.

Authors:  Natalie Justicz; Edie R Hapner; Joshua S Josephs; Benjamin C Boone; Hyder A Jinnah; Michael M Johns
Journal:  Laryngoscope       Date:  2015-07-21       Impact factor: 3.325

6.  The Effects of Remote Signal Transmission and Recording on Acoustical Measures of Simulated Essential Vocal Tremor: Considerations for Remote Treatment Research and Telepractice.

Authors:  Rosemary A Lester-Smith; Charles G Jebaily; Brad H Story
Journal:  J Voice       Date:  2021-10-23       Impact factor: 2.300

Review 7.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Discriminating simulated vocal tremor source using amplitude modulation spectra.

Authors:  Kathy M Carbonell; Rosemary A Lester; Brad H Story; Andrew J Lotto
Journal:  J Voice       Date:  2014-12-19       Impact factor: 2.009

9.  Voice handicap in essential tremor: a comparison with normal controls and Parkinson's disease.

Authors:  Elan D Louis; Marina Gerbin
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-01-09

Review 10.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.